| Bio-Reference Laboratories, Inc. Reports Record Quarterly Revenues (Business Wire) ELMWOOD PARK, N.J.----Bio-Reference Laboratories, Inc. released its second quarter, fiscal year 2010 earnings today for the three months ending April 30. The Company recorded current quarter revenues of $110,447, the best ever quarter in corporate history and an increase of 27% over the $87,183 recorded in the second quarter, fiscal year 2009. us.rd.yahoo.com |
QLT Inc. Q2 2010 Earnings Call Transcript QLT Inc. (QLTI)Q2 2010 Earnings CallJuly 27, 2010 8:30 AM ETComplete Story » seekingalpha.com |
Clearstone Central Laboratories and LabCorp Establish Global Strategic Collaboration for Clinical Trials (PR Newswire) Clearstone Central Laboratories, a leading provider of central laboratory services for late-stage clinical trials, announced today a global collaboration with Laboratory Corporation of America® Holdings through its Esoterix Clinical Trials Services division, providing clients with seamless access to CAP-accredited laboratories across both organizations in Belgium, Canada, China, France, Singapore and the United States. us.rd.yahoo.com |
Spherix Announces Institutional Investors Purchase $5.25 Million of Convertible Preferred Stock and Warrants [PR Newswire] - Spherix Incorporated , an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that it has entered into agreements to sell $5.25 million of shares of its Series B Convertible Preferred Stock and warrants to purchase shares of its common stock in a registered offering to institutional investors. Â Each share of Series B Convertible Preferred Stock is convertible at the option of the holder, at any time during its existence, into approximately 800 shares of common stock at a conversion price of $1.25 per share of common stock for a total of approximately 4.2 million common shares. us.rd.yahoo.com |
PPD Significantly Expands Network of Investigators in Northern India [Business Wire] - PPD, Inc. today announced it has established an agreement with the Himalayan Institute and Hospital Trust , a large teaching hospital in northern India, to create a large investigator site to expand its network of highly qualified investigators in a region that has become increasingly important for conducting global clinical trials. us.rd.yahoo.com |